13‐Methyl‐3‐oxo‐2,3,6,7,8,9,10,11,12,13,14,15,16,17‐tetradecahydro‐1H‐cyclopenta[a]phenanthren‐17‐yl 4‐nitrobenzoate

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-5368|63|6|o3022-o3022

ISSN： 1600-5368

Source： Acta Crystallographica Section E, Vol.63, Iss.6, 2007-06, pp. : o3022-o3022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

13‐Methyl‐3‐oxo‐2,3,8,9,10,11,12,13,14,15,16,17‐dodeca­hydro‐1H‐cyclo­penta­[a]phenanthren‐17‐yl 2‐chloro­acetate

By  

Acta Crystallographica Section E, Vol. 62, Iss. 6, 2006-06 ,pp. : o2442-o2443

John Wiley & Sons Inc

Access to resources Recommend Favorite

10,13,17‐Trimethyl‐3‐oxoperhydro‐1H‐cyclo­penta­[a]phenanthren‐17‐yl chloro­acetate

By  

Acta Crystallographica Section E, Vol. 63, Iss. 1, 2007-01 ,pp. : o86-o87

John Wiley & Sons Inc

Access to resources Recommend Favorite

4‐Methyl‐N‐(3‐oxo‐1,3‐dihydroisobenzofuran‐1‐yl)benzenesulfonamide

By  

Acta Crystallographica Section E, Vol. 63, Iss. 12, 2007-12 ,pp. : o4730-o4730

John Wiley & Sons Inc

Access to resources Recommend Favorite

3‐[(5‐Methyl‐2‐oxo‐1,3‐benzoxazol‐3‐yl)methyl]‐4‐phenyl‐1H‐1,2,4‐triazole‐5(4H)‐thione

By  

Acta Crystallographica Section E, Vol. 63, Iss. 5, 2007-05 ,pp. : o2463-o2463

John Wiley & Sons Inc

Access to resources Recommend Favorite

4‐Allyl‐3‐[(5‐methyl‐2‐oxo‐1,3‐benzoxazol‐3‐yl)methyl]‐1H‐1,2,4‐triazole‐5(4H)‐thione

By  

Acta Crystallographica Section E, Vol. 63, Iss. 5, 2007-05 ,pp. : o2462-o2462

John Wiley & Sons Inc

Access to resources Recommend Favorite